Skip to main content
Signal8

Judy Chou

SEC insider (Form 3/4/5 filer). CIK 0001871695. Director at Akero Therapeutics, Inc. (AKRO). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies Judy Chou has filed insider reports for

  • Akero Therapeutics, Inc. (AKRO): Director
Judy Chou profile photo

Judy Chou

CIK: 0001871695

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Akero Therapeutics, Inc. logo
AKRO

Akero Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Akero Therapeutics, Inc. logo
    AKRO

    Akero Therapeutics, Inc.

    Dec 9, 2025
    Disposition
    Direct
    9.4K shares-
  • Akero Therapeutics, Inc. logo
    AKRO

    Akero Therapeutics, Inc.

    Jun 3, 2025
    Award
    Direct
    9.4K shares-

1-2 of 2